Back

Effects of Shigella diarrhea with and without antibiotic treatment on linear growth: an individual patient data meta-analysis of five multisite studies among children in low-resource settings

Rogawski McQuade, E. T.; Codi, A.; Pavlinac, P. M.; Feutz, E. L.; Kotloff, K. L.; Platts-Mills, J. A.; Benkeser, D.

2026-07-14 infectious diseases
10.64898/2026.07.10.26357688 medRxiv
Show abstract

Background Quantifying the effect of Shigella diarrhea with and without antibiotic treatment on linear growth faltering is critical to understanding the potential impact of Shigella vaccines. Methods Using individual-level data from five multisite studies, we estimated the effect of Shigella diarrhea on length/height-for-age z-score (HAZ) 60-90 days after the episode compared to diarrhea episodes with no etiology identified and non-diarrheal controls. Effects were estimated under treatment with and without antibiotics using augmented inverse probability weighted estimators with ensemble machine learning. Findings Among 26,752 diarrhea episodes, 5,503 (20.6%) were attributed to Shigella and of those, 2,567 (46.6%) were treated with guideline recommended antibiotics. Compared to other diarrhea episodes, Shigella diarrhea without treatment with guideline recommended antibiotics was associated with small reductions in HAZ (HAZ difference: -0.03, 95% CI: -0.05, -0.01), but not when treated with guideline recommended antibiotics (HAZ difference: -0.01, 95% CI: -0.02, 0.01). Compared to non-diarrheal controls, Shigella diarrhea was associated with decrements in HAZ in the following 60-90 days regardless of antibiotic treatment (HAZ difference overall: -0.08, 95% CI: -0.10, -0.07). A larger impact of Shigella diarrhea was observed among younger children. Interpretation Shigella diarrhea was associated with short-term decrements in height. Treatment with guideline recommended antibiotics prevented the impact of Shigella on linear growth compared to other diarrhea episodes but not compared to non-diarrheal controls. These results suggest that improved recognition and treatment or prevention of Shigella could improve child growth.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
PLOS Neglected Tropical Diseases
466 papers in training set
Top 0.9%
13.0%
2
PLOS Medicine
110 papers in training set
Top 0.2%
7.3%
3
PLOS ONE
5266 papers in training set
Top 24%
6.8%
4
BMC Infectious Diseases
133 papers in training set
Top 0.2%
6.3%
5
Vaccine
203 papers in training set
Top 0.6%
5.5%
6
Scientific Reports
3612 papers in training set
Top 23%
4.3%
7
The Journal of Infectious Diseases
202 papers in training set
Top 0.9%
4.1%
8
PLOS Global Public Health
344 papers in training set
Top 4%
4.1%
50% of probability mass above
9
Open Forum Infectious Diseases
142 papers in training set
Top 0.6%
4.1%
10
JAMA Network Open
130 papers in training set
Top 0.8%
4.1%
11
Nature Communications
5641 papers in training set
Top 45%
1.7%
12
American Journal of Epidemiology
67 papers in training set
Top 0.6%
1.7%
13
The American Journal of Tropical Medicine and Hygiene
68 papers in training set
Top 0.9%
1.7%
14
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 28%
1.7%
15
Communications Medicine
113 papers in training set
Top 3%
1.4%
16
JAMA Pediatrics
10 papers in training set
Top 0.1%
1.4%
17
Wellcome Open Research
67 papers in training set
Top 1%
1.1%
18
Epidemics
116 papers in training set
Top 1%
1.1%
19
Clinical Infectious Diseases
235 papers in training set
Top 2%
1.1%
20
BMJ Public Health
25 papers in training set
Top 0.9%
1.1%
21
PLOS Computational Biology
1863 papers in training set
Top 18%
1.0%
22
BMC Medicine
176 papers in training set
Top 4%
1.0%
23
Pediatric Infectious Disease Journal
17 papers in training set
Top 0.3%
1.0%
24
International Journal of Hygiene and Environmental Health
11 papers in training set
Top 0.3%
0.8%
25
Journal of the Pediatric Infectious Diseases Society
10 papers in training set
Top 0.1%
0.8%
26
eLife
5828 papers in training set
Top 64%
0.8%
27
Vaccine: X
22 papers in training set
Top 0.6%
0.8%
28
The Lancet Regional Health - Americas
22 papers in training set
Top 0.7%
0.6%
29
BMJ
51 papers in training set
Top 1%
0.6%